154 related articles for article (PubMed ID: 2709867)
1. Different oxygenators for cardiopulmonary bypass lead to varying degrees of human complement activation in vitro.
Videm V; Fosse E; Mollnes TE; Ellingsen O; Pedersen T; Karlsen H
J Thorac Cardiovasc Surg; 1989 May; 97(5):764-70. PubMed ID: 2709867
[TBL] [Abstract][Full Text] [Related]
2. Complement activation during cardiopulmonary bypass. Comparison of bubble and membrane oxygenators.
Cavarocchi NC; Pluth JR; Schaff HV; Orszulak TA; Homburger HA; Solis E; Kaye MP; Clancy MS; Kolff J; Deeb GM
J Thorac Cardiovasc Surg; 1986 Feb; 91(2):252-8. PubMed ID: 3511328
[TBL] [Abstract][Full Text] [Related]
3. Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation.
van Oeveren W; Kazatchkine MD; Descamps-Latscha B; Maillet F; Fischer E; Carpentier A; Wildevuur CR
J Thorac Cardiovasc Surg; 1985 Jun; 89(6):888-99. PubMed ID: 3158783
[TBL] [Abstract][Full Text] [Related]
4. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations.
Videm V; Svennevig JL; Fosse E; Semb G; Osterud A; Mollnes TE
J Thorac Cardiovasc Surg; 1992 Apr; 103(4):806-13. PubMed ID: 1548925
[TBL] [Abstract][Full Text] [Related]
5. [In vitro and clinical study of complement activation during cardiopulmonary bypass with reference to types of oxygenator, primed autologous blood and patient's factor].
Oda K
Nihon Kyobu Geka Gakkai Zasshi; 1991 Sep; 39(9):1703-11. PubMed ID: 1960449
[TBL] [Abstract][Full Text] [Related]
6. Comparison of bubble and membrane oxygenators in short and long perfusions.
Clark RE; Beauchamp RA; Magrath RA; Brooks JD; Ferguson TB; Weldon CS
J Thorac Cardiovasc Surg; 1979 Nov; 78(5):655-66. PubMed ID: 491720
[TBL] [Abstract][Full Text] [Related]
7. Complement activation with bubble and membrane oxygenators in aortocoronary bypass grafting.
Videm V; Fosse E; Mollnes TE; Garred P; Svennevig JL
Ann Thorac Surg; 1990 Sep; 50(3):387-91. PubMed ID: 2205161
[TBL] [Abstract][Full Text] [Related]
8. Significance of the concentrated red cell and albumin priming method with particular reference to anaphylatoxin generation.
Tamiya T; Maeo Y; Okada T; Ogoshi S; Fujimoto S; Yasui H
J Thorac Cardiovasc Surg; 1992 Jan; 103(1):78-86. PubMed ID: 1728718
[TBL] [Abstract][Full Text] [Related]
9. Cardiopulmonary bypass without systemic heparinization. Performance of heparin-coated oxygenators in comparison with classic membrane and bubble oxygenators.
von Segesser LK; Turina M
J Thorac Cardiovasc Surg; 1989 Sep; 98(3):386-96. PubMed ID: 2770320
[TBL] [Abstract][Full Text] [Related]
10. Time for new concepts about measurement of complement activation by cardiopulmonary bypass?
Videm V; Fosse E; Mollnes TE; Garred P; Svennevig JL
Ann Thorac Surg; 1992 Oct; 54(4):725-31. PubMed ID: 1417231
[TBL] [Abstract][Full Text] [Related]
11. Complement activation during extracorporeal circulation. In vitro comparison of Duraflo II heparin-coated and uncoated oxygenator circuits.
Svennevig JL; Geiran OR; Karlsen H; Pedersen T; Mollnes TE; Kongsgard U; Frøysaker T
J Thorac Cardiovasc Surg; 1993 Sep; 106(3):466-72. PubMed ID: 8361189
[TBL] [Abstract][Full Text] [Related]
12. Platelet function during cardiac operation: comparison of membrane and bubble oxygenators.
Edmunds LH; Ellison N; Colman RW; Niewiarowski S; Rao AK; Addonizio VP; Stephenson LW; Edie RN
J Thorac Cardiovasc Surg; 1982 Jun; 83(6):805-12. PubMed ID: 7087507
[TBL] [Abstract][Full Text] [Related]
13. Development of the oxygenator: past, present, and future.
Iwahashi H; Yuri K; Nosé Y
J Artif Organs; 2004; 7(3):111-20. PubMed ID: 15558331
[TBL] [Abstract][Full Text] [Related]
14. Perfluorocarbon oxygen transport. A comparative study of four oxygenator designs.
Ferguson ER; Clymer JJ; Spruell RD; Holman WL
ASAIO J; 1994; 40(3):M649-53. PubMed ID: 8555594
[TBL] [Abstract][Full Text] [Related]
15. Pressure drop, shear stress, and activation of leukocytes during cardiopulmonary bypass: a comparison between hollow fiber and flat sheet membrane oxygenators.
Gu YJ; Boonstra PW; Graaff R; Rijnsburger AA; Mungroop H; van Oeveren W
Artif Organs; 2000 Jan; 24(1):43-8. PubMed ID: 10677156
[TBL] [Abstract][Full Text] [Related]
16. [Activation of complement during cardiopulmonary bypass--comparative study using 4 different oxygenators].
Soejima K; Koyanagi H; Endo M; Hashimoto A; Imai Y
Nihon Kyobu Geka Gakkai Zasshi; 1987 Feb; 35(2):200-4. PubMed ID: 3495614
[No Abstract] [Full Text] [Related]
17. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins.
Chenoweth DE; Cooper SW; Hugli TE; Stewart RW; Blackstone EH; Kirklin JW
N Engl J Med; 1981 Feb; 304(9):497-503. PubMed ID: 7453783
[TBL] [Abstract][Full Text] [Related]
18. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure.
Seghaye MC; Duchateau J; Grabitz RG; Faymonville ML; Messmer BJ; Buro-Rathsmann K; von Bernuth G
J Thorac Cardiovasc Surg; 1993 Dec; 106(6):978-87. PubMed ID: 8246580
[TBL] [Abstract][Full Text] [Related]
19. Fate of indium 111-labeled platelets during cardiopulmonary bypass performed with membrane and bubble oxygenators.
Peterson KA; Dewanjee MK; Kaye MP
J Thorac Cardiovasc Surg; 1982 Jul; 84(1):39-43. PubMed ID: 7087539
[TBL] [Abstract][Full Text] [Related]
20. Complement activation and bioincompatibility. The terminal complement complex for evaluation and surface modification with heparin for improvement of biomaterials.
Mollnes TE; Videm V; Riesenfeld J; Garred P; Svennevig JL; Fosse E; Hogasen K; Harboe M
Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):21-6. PubMed ID: 1934602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
